AMY ODOM: Open Payments
NPI 1750863726 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 30 payments from 13 companies in 2025. Trend: 2023 $72 · 2024 $335 · 2025 $655
Food & beverage: $655
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 3 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Viatris Specialty LLC | 3 | $50 |
| Mallinckrodt Hospital Products Inc. | 1 | $40 |
| Grifols USA, LLC | 1 | $31 |
| GENZYME CORPORATION | 1 | $21 |
| Verona Pharma, Inc. | 1 | $20 |
Products named: XYWAV, GLASSIA, NUCALA, YUPELRI, JASCAYD, ACTHAR, DUPIXENT, OFEV.
Industry payments across AL — which companies pay providers there.
